More names will soon be added to the line-up, stay tuned!

Jean Tirole is chairman of the Toulouse School of Economics (TSE) and the Institute for Advanced Study in Toulouse (IAST), which he helped found in 2011. He is also affiliated with the Massachusetts Institute of Technology, where he holds a visiting position, the Ecole des Hautes Etudes en Sciences Sociales, and the Académie des sciences morales et politiques. Professor Tirole’s research covers industrial organization, regulation, finance, macroeconomics and banking, and psychology-based economics. Jean Tirole has published over two hundred articles in international reviews, as well as twelve scientific books. His latest book entitled Economics for the Common Good, accessible to a wide audience, is under translation into fifteen languages. He is laureate of numerous international distinctions, including the 2007 CNRS gold medal and the 2014 Sveriges Riksbank prize in economic sciences in memory of Alfred Nobel.

Catherine Geslain-Lanéelle is General Director for the Economic and Environmental Performance of Enterprises at the French Minsitry of Agriculture and Nutrition.
Between 2006 and 2013, she was Executive Director of European Food Safety Authority (EFSA) in Parma (Italy). From 2003 to 2006, she was General Director of Nutrition in the French Ministry of Agriculture and Fisheries. Prior to 2003, she worked for the European Commission in the Ministry of Agriculture.

Christophe Dardel currently serves as the CEO of EnobraQ, a French synthetic biology start up founded in 2015 leveraging patented pending breakthrough technologies developed within the Toulouse White Biotechnology cluster (TWB). EnobraQ is unlocking the use of CO2 as an industrial fermentation feedstock enabling large commodity chemicals to be produced in a sustainable manner, both economically and ecologically. Before joining EnobraQ in February 2017, Christophe served for seven years as President & CEO of DSM Biomedical in the USA where he was responsible for growing the business’s global activities that included the acquisition of Kensey Nash, a leading regenerative medicine company. Christophe was also a Board Member of Actamax® a DSM/DuPont Joint Venture. Before joining DSM Biomedical in May 2010, Christophe served for eight years as President of DSM Dyneema, the inventor and manufacturer of Dyneema®, the world’s strongest fiber™. In 2003 he was also appointed board member of Nippon Dyneema Co., Ltd – a joint venture of Toyobo and DSM. Prior to joining DSM in 2002, Christophe held several positions within 3M and E. I. du Pont de Nemours. Christophe earned his Masters of Science degree in Computer Science, Electronics and Automation from ESIEA in Paris.

Lionel Clarke co-chairs the UK Synthetic Biology Leadership Council (SBLC), having previously chaired the UK Synthetic Biology Roadmap Coordination Group, which issued the UK Synthetic Biology Roadmap in July 2012. His current co-chair on the SBLC is Lord Henley, having previously co-chaired with Lord Willetts, George Freeman, MP and Lord Prior of Brampton. The SBLC oversees implementation and updating of the UK Roadmap, and issued ‘Biodesign for the Bioeconomy’ a Strategic Plan for UK Synthetic Biology 2016. He is an advisory Board member to the UK government’s Business, Environment and Industrial Strategy department (BEIS) developing a strategy for the Bioeconomy as a contribution towards the UK Industrial Strategy. Research Fellowships at the Cavendish Laboratory Cambridge (Trinity College and Peterhouse), and a Royal Society European Research Fellowship in Grenoble, France, followed his graduation in physics from Imperial College London, alongside a teaching diploma from the Royal Academy of Music. He subsequently gained extensive industrial research experience working for Royal Dutch Shell, forming numerous academic and industrial partnerships to take innovative ideas for better fuels and technologies from laboratory through to global markets. He is a visiting professor in the Department of Bioengineering in Imperial College, and holds an honorary chair in the Faculty of Life Sciences at the Manchester Institute of Biotechnology. He holds advisory team and board member/chairman roles in several UK universities, the Engineering and Physical Sciences research council and the Royal Academy of Engineering, and was a contributor to the US National Research Council document ‘Industrialization of Biology’ 2015. He is founder and director of BionerG, a UK-based bio-environmental consultancy company.

Christophe founded Genomatica in 1998. Since being named CEO in May 2009, he has led Genomatica to widespread recognition as a leader in industrial biotech, with a commercialized first process and plant (for 1,4-butanediol), a second process in early commercialization (for Brontide™ butylene glycol, winner of the ICIS Innovation Award), and multiple leading partners. The company has earned awards for industry impact (ICIS Top40 Power Players six years in a row, and highest rating for sustainability technology in 2017 ICIS survey), engineering (Kirkpatrick Award), science (EPA Presidential Green Chemistry), industry leadership (voted #1 Hottest in renewable chemicals four years in a row by Biofuels Digest), and company culture (The Scientist as a Best Place to Work). Christophe is Chairman Elect for Biocom, the largest advocate organization for California’s life sciences sector; serves on the World Economic Forum Global Agenda Council on Biotechnology; and is a member of YPO, an international leadership organization for chief executives. Christophe holds a Ph.D. in bioengineering from the University of California, San Diego. He received a B.S. in biomedical engineering from Duke University and was honored as a Distinguished Young Alumnus in 2010.

Veronique de Bruijn (MSc MBA) is CEO Photanol since 2016. Previously acting as Investment Director at ICOS Capital a Amsterdam based clean tech VC, she co-lead the investment in Photanol and managed the spin-out of the company, build out of the team and realised strategic partnerships with top tier global players such as Akzo Nobel. Prior to this, she raised early-stage funding for 3 start-ups in the capacity of independent advisor and lead operational / engineering teams from the desert of Tunisia, in the mangroves of Nigeria to offshore Canada (and back ).

Christian was one of the early investors in CelluComp. In 2011, he became Chief Executive Officer and executive director. Christian came to CelluComp with extensive operational business experience in the clothing/textile industry and a strong knowledge in brand-building, sustainability and social enterprise. Prior to CelluComp, Christian was Chief Executive Officer for EDUN, a company owned by Bono (of U2). 49% of the company was eventually sold to LVMH. Prior to EDUN, Christian was Managing Director at Lacoste for product development and communication worldwide, a position he held for 5 years. Previously, Christian was European Licensing Director for Disney Consumer Products and Director of European purchasing for Polo Ralph Lauren. Christian is a graduate of Princeton University in USA and resides in France with his wife and 5 children.

Sean Sutcliffe has served as Chief Executive of Green Biologics since April 2008, contributing to the company extensive commercial and operational experience across the energy and renewables sector. Prior to joining Green Biologics he was from 2005 Chief Executive of Biofuels Corporation, a UK based biodiesel producer, and from 2007 Chairman of Tidal Generation Limited, a developer of tidal stream devices. Previously Sean worked for BG Group Plc. for 14 years in a variety of roles spanning operations, business development and strategy, most recently as Executive Vice President with responsibility for Corporate Development and New Businesses. Sean is a Chartered Mechanical Engineer with an Engineering degree from Cambridge University and a non executive director of Keit Spectrometers, a company commercialising instruments for manufacturing industries.

Henrik Busch-Larsen has been the CEO of Unibio Group since 2012. He has served as an Army Officer, holds a master’s degree in International Business, and is currently enrolled in an MBA program. Henrik Busch-Larsen has 10 years of experience working with Unibio both as a board member, sales and marketing director and now CEO. Before joining the Unibio team, he founded a technology start-up working within applied artificial intelligence. His ambition is to build a strong reputable business around the U-Loop technology and bring Uniprotein®, a bacterial protein to the world market. The main vision for Unibio is to take part in resolving the World’s protein scarcity challenge by decoupling protein production from the fluctuating agriculture and stressed fishing industries, and thus freeing up agricultural land for food for humans rather than feed for animals. In 2015 Unibio won the EY Entrepreneur of the Year in the Life Sciences Category.

Prof. Ludo Diels, Dr. in chemistry & biotechnology, works at the University of Antwerp, and is research manager Sustainable Chemistry for the Flemish Institute for Technological Research (VITO) in Mol, Belgium.

Marcel van Berkel studied Chemistry and Business Administration in Utrecht, The Netherlands. He worked for more than 20 years for corporate companies like Solvay and DSM. Marcel left DSM a few years back to expedite the growth of a start-up in the bio-based chemicals industry. After completing this successfully, he started his own consultancy firm VanBerkel Consultancy. With experience in business development, business strategy, marketing & branding and business management, VanBerkel Consultancy offers support in defining and executing your business development and market strategy and can help companies expand to oversees areas.